Improving site-sponsor-CRO relationship

November 2009
Clinical Trials Administrator;Nov2009, Vol. 7 Issue 11, p127
This article offers some tips on improving relations between clinical trial (CT) sites, sponsors, and clinical research organizations (CROs). It advises sponsors to solicit input from CT researchers to resolve problems involving protocols. It also recommends the initiation of feasibility assessments to prevent recruitment and enrollment problems facing CT sites. In addition, the article suggests how to handle delays and resolve complaints from CROs.


Related Articles

  • Removing the Mystique. Pellegrino, Jill; Smith, Roger // Applied Clinical Trials;Mar2009, Vol. 18 Issue 3, p85 

    The article discusses the predictive enrollment model that allows clinical trial professionals to invest in recruitment. The model was based on calculating the interaction between the two principles in order to predict enrolment such as protocol feasibility and recruitment stage timing. A...

  • Improving Health Worker Adherence to Malaria Treatment Guidelines in Papua New Guinea: Feasibility and Acceptability of a Text Message Reminder Service. Kurumop, Serah F.; Bullen, Chris; Whittaker, Robyn; Betuela, Inoni; Hetzel, Manuel W.; Pulford, Justin // PLoS ONE;Oct2013, Vol. 8 Issue 10, p1 

    The aim of this study is to assess whether a text message reminder service designed to support health worker adherence to a revised malaria treatment protocol is feasible and acceptable in Papua New Guinea (PNG). The study took place in six purposively selected health facilities located in the...

  • A Model-Based Method for Improving Protocol Quality. Kahn, Michael G.; Broverman, Carol A.; Wu, Nancy; Farnsworth, Wendy J.; Manlapaz-Espiritu, Lenilyn // Applied Clinical Trials;May2002, Vol. 11 Issue 5, p40 

    Focuses on an approach to improve clinical trial protocols. Increase in the operational-management of clinical trials due to complexity of protocols; Distinction between scientific and operational issues in clinical trials planning and execution; Reduction of the risk of protocol...

  • What Is a Subject Diary, and How Do Regulations Apply? Stokes, Teri; Paty, Jean // Applied Clinical Trials;Sep2002, Vol. 11 Issue 9, p38 

    Part I. Discusses the use of subject diaries in clinical trials and the way researchers can comply with applicable regulations and guidelines. Types of diary technologies; Regulations and guidelines that must be followed to obtain high standards of data quality set by regulatory bodies; Audit...

  • Notes from the field. Sadowski, Lynn // Applied Clinical Trials;Sep2002, Vol. 11 Issue 9, p56 

    Provides tips on building and maintaining monitor-coordinator relationships in clinical trials. Emphasis on strengths of both monitor and coordinator; Definition of expectations; Avoidance of coordinator isolation; Noting of issues onsite and working with coordinator to develop acceptable...

  • Aide-memoire for preparing clinical trial protocols.  // British Medical Journal;5/21/1977, Vol. 1 Issue 6072, p1323 

    Presents a list of elements for preparing clinical trial protocols. Amplification of several headings through footnotes; Revisions in trial techniques; Inclusion of legal and ethical obligations.

  • A sponsor's perspective in negotiating fair terms.  // Clinical Trials Administrator;Nov2009, Vol. 7 Issue 11, p128 

    This article looks at some of the negotiating issues between clinical trial (CT) sponsors and sites. It begins with the disagreement between CT sponsors and sites on initial payments, marketing, recruiting, advertising fees, and milestone payments. It then explains the move of sponsors to raise...

  • COMMENTARY. Kennard, Jerry // International Journal of Therapy & Rehabilitation;May2005, Vol. 12 Issue 5, p221 

    The article presents the author's comments on a paper by Ros Jhonson related to the approach to interprofessional education (IPE) at the pre-registration level. Jhonson states that IPE is often viewed as a subject-based modular entry, which makes people miss the point of what it is really trying...

  • Key feasibility considerations when conducting vaccine clinical trials in Asia-Pacific countries. Lansang, Elvira Zenaida; Kenneth, Tan; Nayak, Saumya; Lee, Ken J.; Karen, Wai // Vaccine: Development & Therapy;2013, Vol. 3, p1 

    Introduction: Conducting clinical trial feasibility is an important first step in initiating a clinical trial. A robust feasibility process ensures that a realistic capability assessment is made before conducting a trial. A retrospective analysis of vaccine clinical trials was performed to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics